Kestra Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Sell |
25,556
-3,846
| -13% | -$1.56M | 0.05% | 367 |
|
|
2025
Q1 | $14.6M | Sell |
29,402
-963
| -3% | -$479K | 0.07% | 249 |
|
|
2024
Q4 | $15.8M | Buy |
30,365
+1,026
| +3% | +$534K | 0.09% | 240 |
|
|
2024
Q3 | $18.1M | Sell |
29,339
-1,124
| -4% | -$695K | 0.1% | 213 |
|
|
2024
Q2 | $16.2M | Buy |
30,463
+1,876
| +7% | +$1,000K | 0.09% | 240 |
|
|
2024
Q1 | $16.6M | Buy |
28,587
+2,176
| +8% | +$1.26M | 0.11% | 182 |
|
|
2023
Q4 | $14M | Sell |
26,411
-603
| -2% | -$320K | 0.11% | 194 |
|
|
2023
Q3 | $13.7M | Buy |
27,014
+3,666
| +16% | +$1.86M | 0.13% | 169 |
|
|
2023
Q2 | $12.2M | Sell |
23,348
-1,104
| -5% | -$576K | 0.12% | 191 |
|
|
2023
Q1 | $14.1M | Sell |
24,452
-10,722
| -30% | -$6.18M | 0.15% | 147 |
|
|
2022
Q4 | $19.4M | Buy |
35,174
+12,886
| +58% | +$7.1M | 0.17% | 134 |
|
|
2022
Q3 | $11.3M | Sell |
22,288
-587
| -3% | -$298K | 0.12% | 192 |
|
|
2022
Q2 | $12.4M | Buy |
22,875
+3,513
| +18% | +$1.91M | 0.13% | 175 |
|
|
2022
Q1 | $11.4M | Buy |
19,362
+212
| +1% | +$125K | 0.12% | 193 |
|
|
2021
Q4 | $12.8M | Buy |
19,150
+244
| +1% | +$163K | 0.13% | 179 |
|
|
2021
Q3 | $10.8M | Buy |
18,906
+844
| +5% | +$482K | 0.11% | 208 |
|
|
2021
Q2 | $9.11M | Sell |
18,062
-782
| -4% | -$395K | 0.1% | 218 |
|
|
2021
Q1 | $8.6M | Buy |
18,844
+6,718
| +55% | +$3.07M | 0.11% | 216 |
|
|
2020
Q4 | $5.6M | Buy |
12,126
+12,024
| +11,788% | +$5.55M | 0.06% | 305 |
|
|
2020
Q3 | $3.62M | Buy |
+102
| New | +$3.62M | 0.07% | 295 |
|